Detection of ∆9-THC in cerebrospinal fluid: new validation strategies for forensic and clinical toxicology applications

This publication has 29 references indexed in Scilit:

• LC–MS/MS quantification of olanzapine in hair after alkaline digestion
  Drug Testing and Analysis, 2024
• Investigating surrogate cerebrospinal fluid matrix compositions for use in quantitative LC-MS analysis of therapeutic antibodies in the cerebrospinal fluid
  Analytical and Bioanalytical Chemistry, 2020
• Cannabis edibles: dosing, encapsulation, and stability considerations
  Current Opinion in Food Science, 2019
• Investigation of utility of cerebrospinal fluid drug concentration as a surrogate for interstitial fluid concentration using microdialysis coupled with cisternal cerebrospinal fluid sampling in wild-type and Mdr1a(−/−) rats
  Drug Metabolism and Pharmacokinetics, 2016
• Cannabis use: a perspective in relation to the proposed UK drug‐driving legislation
  Drug Testing and Analysis, 2013
• Distribution of free and conjugated cannabinoids in human bile samples
  Forensic Science International, 2012
• A validated GC–MS method for the determination of Δ9-tetrahydrocannabinol and 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid in bile samples
  Forensic Toxicology, 2011
• Postmortem redistribution of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH)
  Forensic Science International, 2011
• A preliminary investigation on the distribution of cannabinoids in man
  Forensic Science International, 2011
• Direct in vivo comparison of two mechanisms releasing dopamine in the rat striatum
  Brain Research, 1995